BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34634626)

  • 1. Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis.
    Jons D; Persson Berg L; Sundström P; Haghighi S; Axelsson M; Thulin M; Bergström T; Andersen O
    Mult Scler Relat Disord; 2021 Nov; 56():103288. PubMed ID: 34634626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment.
    Persson Berg L; Eriksson M; Longhi S; Kockum I; Warnke C; Thomsson E; Bäckström M; Olsson T; Fogdell-Hahn A; Bergström T
    BMJ Neurol Open; 2022; 4(2):e000271. PubMed ID: 35978722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen.
    Persson Berg L; Thomsson E; Hasi G; Bäckström M; Bergström T
    J Virol Methods; 2020 Oct; 284():113927. PubMed ID: 32650039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
    Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
    Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
    PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
    Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
    Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.
    Jons D; Zetterberg H; Malmeström C; Bergström T; Axelsson M; Blennow K; Thulin M; Sundström P; Andersen O
    Acta Neurol Scand; 2020 Aug; 142(2):161-168. PubMed ID: 32415852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
    Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
    J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epstein-Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases.
    Xu J; Ahmad A; Blagdon M; D'Addario M; Jones JF; Dolcetti R; Vaccher E; Prasad U; Menezes J
    Int J Cancer; 1998 Oct; 79(5):481-6. PubMed ID: 9761116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
    Mameli G; Madeddu G; Mei A; Uleri E; Poddighe L; Delogu LG; Maida I; Babudieri S; Serra C; Manetti R; Mura MS; Dolei A
    PLoS One; 2013; 8(11):e78474. PubMed ID: 24236019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hospital based pilot study on Epstein-Barr virus in suspected infectious mononucleosis pediatric patients in India.
    Janani MK; Malathi J; Appaswamy A; Singha NR; Madhavan HN
    J Infect Dev Ctries; 2015 Oct; 9(10):1133-8. PubMed ID: 26517489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage.
    Jons D; Grut V; Bergström T; Zetterberg H; Biström M; Gunnarsson M; Vrethem M; Brenner N; Butt J; Blennow K; Nilsson S; Kockum I; Olsson T; Waterboer T; Sundström P; Andersen O
    J Neurol Neurosurg Psychiatry; 2024 Mar; 95(4):325-332. PubMed ID: 37802637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis.
    Mueller NE; Lennette ET; Dupnik K; Birmann BM
    Int J Cancer; 2012 Jun; 130(12):2886-91. PubMed ID: 21805472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom.
    Kuri A; Jacobs BM; Vickaryous N; Pakpoor J; Middeldorp J; Giovannoni G; Dobson R
    BMC Public Health; 2020 Jun; 20(1):912. PubMed ID: 32532296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression.
    Tao C; Simpson-Yap S; Taylor B; Blizzard L; Lucas R; Ponsonby AL; Broadley S; van der Mei I;
    Mult Scler Relat Disord; 2022 Mar; 59():103561. PubMed ID: 35131728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of infectious mononucleosis caused by Epstein-Barr virus in infants.
    Dohno S; Maeda A; Ishiura Y; Sato T; Fujieda M; Wakiguchi H
    Pediatr Int; 2010 Aug; 52(4):536-40. PubMed ID: 20113421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus candidate genes and multiple sclerosis.
    Claire Simon K; Schmidt H; Loud S; Ascherio A
    Mult Scler Relat Disord; 2015 Jan; 4(1):60-4. PubMed ID: 25787055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
    Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
    BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.